26 September 2024 - BEAM AllianceNew York, From inside the UN buildings – Remko van LeeuwenJust a few hours ago the General Assembly of the UN has adopted a new declaration on fighting AMR. Regardless…read more >>
17 September 2024 - BEAM AllianceBEAM’s Reflection paper on General Pharmaceutical Legislation Revision: Taking Stock of the EU Parliament Position and Moving ForwardThe BEAM Alliance would like to reiterate its call for optimal PULL incentives designed to fit innovators’ needs based on…read more >>
24 October 2023 - BEAM AllianceBEAM Alliance shares its views on the ongoing revision of the General Pharmaceutical LegislationWe call on policymakers to stop postponing decisions and either propose a clear incentive package now or reintroduce the TEE…read more >>
05 September 2023 - BEAM AllianceBEAM Alliance is Launching a new Task Force to address Issues from the AMR Diagnostics SegmentThe new Task Force is gathering innovative SMEs operating in the AMR field and external experts.read more >>
16 June 2023 - BEAM AllianceBEAM’s reflection paper on the possible roles of DG HERAThe report represents an important step towards the implementation of a tangible solution to fix the AMR market. Although the…read more >>
23 May 2023 - BEAM AllianceBEAM’s statement on the EU Council Recommendation on AMRThe proposal examines AMR in a rather exhaustive way. It includes provisions on the need to strengthen national action plans,…read more >>
16 December 2024 - BasileaBasilea announces agreement with Innoviva Specialty Therapeutics for the commercialization of antibiotic Zevtera® (ceftobiprole) in the United StatesCeftobiprole, the active moiety of the prodrug ceftobiprole medocaril, is an advanced generation cephalosporin antibiotic for intravenous administration, with rapid…read more >>
25 November 2024 - Centauri Therapeutics LtdCentauri Therapeutics awarded £1M grant under new PACE programme to advance immunotherapy platform in anti-infectives“We are excited to have support from PACE as we progress the development of our molecules in anti-infectives, and de-risk…read more >>
21 November 2024 - Debiopharm InternationalCARB-X Awards Additional Funding to Debiopharm for Continued Development of Early-Stage Antibiotic Targeting Drug-Resistant N. Gonorrhoeae InfectionsNow more than ever, new antibiotics are needed to avoid serious public health consequences caused by this infection.read more >>
13 November 2024 - AktheliaAkthelia Pharmaceuticals featured in Icelandic newspaper ViðskiptablaðiðThe article highlights the opportunity to advance our highly promising oral NCE therapeutic asset Gastrimod™️ (AKT-011) that we are exploring…read more >>
04 November 2024 - PHAXIAMPHAXIAM Therapeutics Receives FDA Clearance to Initiate Phase II GLORIA Study in the U.S.This FDA IND clearance is a major recognition of our therapeutic approach and of our whole platform. This is a…read more >>
30 October 2024 - Thioredoxin Systems ABTXN Systems Raises SEK 25 Million Series A to Advance First-in-Class AntibioticWith its novel mechanism of action on a new target, and extensive testing that has demonstrated its effectiveness against a…read more >>
30 August 2022CDC/FDA Public Online Workshop: Drug Development Considerations for the Prevention of HealthCare-Associated InfectionsThe Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) are co-sponsoring this public virtual workshop.read more >>
23 August 2022REVIVE Webinar: Challenges of developing antibiotic combinationsREVIVE is a space for everybody with an interest in antimicrobial R&D.read more >>
10 August 2022REVIVE Webinar: Animal models to study the activity of antibioticsREVIVE is a space for everybody with an interest in antimicrobial R&D.read more >>
26 July 2022REVIVE Webinar: New approaches to antibiotic discoveryREVIVE is a space for everybody with an interest in antimicrobial R&D.read more >>
22 June 2022JPIAMR Innovation Online Workshop: Developing Diagnostic tools for Drug Resistant Infections for Human and Animal HealthJPIAMR, in partnership with Innovate UK KTN, are hosting this innovation workshop to provide information about the challenges in translating…read more >>
21 June 2022JPIAMR Innovation Online Workshop: Developing Novel Antimicrobial TherapeuticsJPIAMR, in partnership with Innovate UK KTN, are hosting this innovation workshop to provide information about the challenges in translating…read more >>
08 June 2022COMBINE Expert Workshop on Monoclonal Antibodies for AMR PathogensThe Paul-Ehrlich-Institut, on behalf of the COMBINE project, is organising a two-day, free, virtual workshop to discuss recurring challenges and…read more >>
07 April 20226th AMR ConferenceThe AMR conference is a platform for SMEs, start-ups, big pharma, academia, investors and public institutions to discuss strategies and…read more >>
28 March 2022BIO-Europe Spring 2022: 16th Annual International Partnering Conference: a 100% digital event.The sixteenth annual BIO-Europe Spring® conference will bring together the life science community for global dealmaking in-person and digitally.read more >>
